israel journal of
psychiatry
In schizophrenia, how do you get from here
Vol. 48 - Number 2 2011
ISSN: 0333-7308
74
Rates of Expressed Emotions in Pakistani Relatives of Patients with Schizophrenia Aisha Ikram et al.
Volume 48, Number 2, 2011 Israel Journal of Psychiatry and Related Sciences
82
to here? Xeplion®, a new once-monthly injectable schizophrenia therapy,1 significantly reduces relapse.2 With early onset of efficacy3,4 and good tolerability,1–6 Xeplion can help your patients shape a future in a way that they wish.
Preventive Pharmacological Treatment – an Evolving new Concept in Schizophrenia Rony Sabbag et al.
91
Virtual Reality Exposure versus Cognitive Restructuring for Treatment of Public Speaking Anxiety Helene S. Wallach et al.
98
Social Cognition in Social Anxiety: First Evidence for Increased Empathic Abilities Yasmin Tibi-Elhanany et al.
107
Responsibility of the Therapist for the Patients' Actions (Tarasoff Rules) Yuval Melamed et al.
111
ICD-10 Psychosocial Categories and Psychiatric Diagnosis Silvana Fennig et al.
117
Family variables related to behavioral problems in childhood Antonio Félix Raya et al.
123
Relationship between Personality and Disability in Patients with Major Depressive Disorder Medine Yazıcı Gűleç, Çiçek Hocaoğlu
129
Tachyphylaxis/ Tolerance to Preventing relapse, enabling futures
Antidepressive Medications: A Review
Gregory Katz
For comprehensive information please refer to full Prescribing information as approved by the Israeli Health Authority.
136
References: 1. Xeplion prescribing information. 2. Hough D et al. Schiz Res 2010; 116: 107-117. 3. Pandina GJ et al. J Clin Psychopharmacol 2010; 30: 235-244. 4. Kramer M et al. Int J Neuropsychopharmacol 2010; 13: 635-647. 5. Gopal S et al. J Psychopharmacol Online First, published on July 8, 2010 as doi:10.1177/0269881110372817. 6. Hoy SM et al. CNS Drug Rev 2010; 24(3): 227-244.
Controversies in Psychiatry: Proceedings of the first Psychiatric Residents Interactive Course.